Odey Asset Management Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
Odey Asset Management Group's XLRN Position: Q4 2021 in Review
Odey Asset Management Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 33,800 shares — an estimated $5.82M sold.
Odey Asset Management Group first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $5.82M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Odey Asset Management Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Odey Asset Management Group sold 33,800 Acceleron Pharma shares in Q4 2021, an estimated $5.82M.
- Odey Asset Management Group first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
- Odey Asset Management Group's Acceleron Pharma position peaked at $5.82M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Odey Asset Management Group's 13F filing for Q4 2021, filed 14 Feb 2022.